Please login to the form below

Not currently logged in
Email:
Password:

BTG acquires Roxwood Medical

Will pay up to $80m for the catheter specialist

BTGGlobal healthcare company BTG has acquired Roxwood Medical, a provider of cardiovascular speciality catheters used to treat patients with severe coronary and peripheral artery disease.

John Sylvester, BTG’s chief commercial officer, said: “This bolt-on acquisition continues to build BTG’s strength in the interventional vascular space, further expanding our portfolio of differentiated minimally invasive vascular technologies.”

The healthcare group will pay $65m on closing and a further $15m should Roxwood achieve certain commercial milestones.

Mehrdad Farhangnia, chief executive officer at Roxwood, said: “This is an exciting new chapter for the team at Roxwood and further testament to the utility of the anchoring and microcatheter platforms.

“With the expanded commercial and clinical reach of BTG, these minimally invasive tools can help far more clinicians successfully treat patients with severe arterial blockages.”

Article by
Gemma Jones

6th October 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...

Infographics